NICE Information Service, an international credit assessment company, and Korea Enterprise Data have rated “Unique Biotech” as a [Company with Excellent Technical Capabilities] through their assessment.

These technical credit evaluations are done, based on a company’s technical capability and credit rating by the tech credit bureaus (TCBs) and frequently used by financial institutions when they decide on whether to make loans to the company. This evaluation includes the technological information of the company, in addition to its financial data, with a view to increasing the accuracy of the TCBs’ prediction about its credit rating.

The technology credit assessment done by a TCB is classified into 10 classes (T1~T10), in which our company receives [T3] this time that is eligible to be called as a [company with excellent technical capabilities]. The class “T3” is given to a company that boasts of technical capability high enough to deserve being listed on the Korean Securities Dealers Automated Quotations (KOSDAQ), equivalent to US NASDAQ, under special provisions.